Women with ER positive disease appeared to have a greater breast cancer survival disparity than their counterparts with ER negative disease (p-value for interaction = .0001 for Black, .006 for Hispanic, and .32 for American Indian/Alaska Native, relative to White Non-Hispanic women). This evidence concerns the gene ESR1 and breast carcinoma.